Publications

Association between obstructive sleep apnoea and liver fibrosis in patients with suspected nonalcoholic fatty liver disease. 

Trzepizur W, Boursier J, Poilane J, Bureau C, Sedkaoui K, Pontier S, Costentin C, Pépin JL, Schnee M, Bizieux A, Guillaume M, Hamel JF, Gagnadoux F. Sleep. 2025 Aug 30:zsaf265. doi: 10.1093/sleep/zsaf265. Online ahead of print. PMID: 40884485

A Novel Risk Prediction Model for Hepatocellular Carcinoma in MASLD: A Multinational, Multicenter Cohort Study.

Chun HS, Lee M, Lee HA, Park ES, Choi JY, Baek HS, Kim TH, Lin H, Cheuk-Fung Yip T, Lee HW, Tsochatzis E, Petta S, Bugianesi E, Yoneda M, Zheng MH, Hagström H, Boursier J, Calleja JL, Boon-Bee Goh G, Chan WK, Gallego-Durán R, Sanyal AJ, de Lédinghen V, Newsome PN, Fan JG, Castéra L, Lai M, Harrison S, Fournier-Poizat C, Lai-Hung Wong G, Pennisi G, Armandi A, Nakajima A, Liu WY, Shang Y, de Saint-Loup M, Llop E, Jun Teh KK, Lara-Romero C, Asgharpour A, Mahgoub S, Sau-Wai Chan M, Romero-Gomez M, Wai-Sun Wong V, Kim SU. Clin Gastroenterol Hepatol. 2025 Jul 10:S1542-3565(25)00569-5. doi: 10.1016/j.cgh.2025.06.025. Online ahead of print. PMID: 40645391

Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease.

Lai JC, Yang B, Lee HW, Lin H, Tsochatzis EA, Petta S, Bugianesi E, Yoneda M, Zheng MH, Hagström H, Boursier J, Calleja JL, Goh GB, Chan WK, Gallego-Duràn R, Sanyal AJ, de Lédinghen V, Newsome PN, Fan JG, Castera L, Lai M, Fournier-Poizat C, Wong GL, Pennisi G, Armandi A, Nakajima A, Liu WY, Shang Y, Saint-Loup M, Llop E, Teh KKJ, Lara-Romero C, Asgharpour A, Mahgoub S, Chan MS, Canivet CM, Romero-Gómez M, Kim SU, Wong VW, Yip TC. Gut. 2025 Jul 17:gutjnl-2025-334981. doi: 10.1136/gutjnl-2025-334981. Online ahead of print. PMID: 40541300

Non-invasive tests developed using artificial intelligence for screening in MASLD: interest and pitfalls.

Boursier J, Cariou B. J Clin Endocrinol Metab. 2025 May 19:dgaf294. doi: 10.1210/clinem/dgaf294. Online ahead of print. PMID: 40388374 No abstract available.

Non-invasive tests for fibrotic MASH for reducing screen failure in therapeutic trials.

Fichez J, Mouillot T, Vonghia L, Costentin C, Moreau C, Roux M, Delamarre A, Francque S, Zheng MH, Boursier J. JHEP Rep. 2025 Feb 4;7(4):101351. doi: 10.1016/j.jhepr.2025.101351. eCollection 2025 Apr. PMID: 40212791 Free PMC article.

SIAD (Societé d'Imagerie Abdominale et Digestive) and AFEF (Association Française pour l'Etude du Foie) best practice position paper on the implementation of ultrasound elastography in clinical practice.

Parlati L, Aubé C, Lewin M, Boursier J, Ronot M, Paisant A; Collaborative authors (Delphi Panel Group). Diagn Interv Imaging. 2025 Jul-Aug;106(7-8):272-279. doi: 10.1016/j.diii.2025.03.010. Epub 2025 Apr 9. PMID: 40210513

Biomarkers of Histological Response in Lanifibranor-treated Patients With Metabolic Dysfunction-associated Steatohepatitis.

Boursier J, Hervé H, Roux M, Abdelmalek MF, Francque SM, Broqua P, Junien JL, Abitbol JL, Huot-Marchand P, Dzen L, Cooreman MP, Patel S. Clin Gastroenterol Hepatol. 2025 Mar 17:S1542-3565(25)00204-6. doi: 10.1016/j.cgh.2024.12.039. Online ahead of print. PMID: 40107637

Metabolic dysfunction-associated steatotic liver disease in adults.

Huang DQ, Wong VWS, Rinella ME, Boursier J, Lazarus JV, Yki-Järvinen H, Loomba R. Nat Rev Dis Primers. 2025 Mar 6;11(1):14. doi: 10.1038/s41572-025-00599-1. PMID: 40050362 Review.

Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021. 

Feng G, Targher G, Byrne CD, Yilmaz Y, Wai-Sun Wong V, Adithya Lesmana CR, Adams LA, Boursier J, Papatheodoridis G, El-Kassas M, Méndez-Sánchez N, Sookoian S, Castera L, Chan WK, Ye F, Treeprasertsuk S, Cortez-Pinto H, Yu HH, Kim W, Romero-Gómez M, Nakajima A, Win KM, Kim SU, Holleboom AG, Sebastiani G, Ocama P, Ryan JD, Lupșor-Platon M, Ghazinyan H, Al-Mahtab M, Hamid S, Perera N, Alswat KA, Pan Q, Long MT, Isakov V, Mi M, Arrese M, Sanyal AJ, Sarin SK, Leite NC, Valenti L, Newsome PN, Hagström H, Petta S, Yki-Järvinen H, Schattenberg JM, Castellanos Fernández MI, Leclercq IA, Aghayeva G, Elzouki AN, Tumi A, Sharara AI, Labidi A, Sanai FM, Matar K, Al-Mattooq M, Akroush MW, Benazzouz M, Debzi N, Alkhatry M, Barakat S, Al-Busafi SA, Rwegasha J, Yang W, Adwoa A, Opio CK, Sotoudeheian M, Wong YJ, George J, Zheng MH. JHEP Rep. 2024 Nov 14;7(3):101271. doi: 10.1016/j.jhepr.2024.101271. eCollection 2025 Mar. PMID: 39980749

Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLD.

Vali Y, van Dijk AM, Lee J, Boursier J, Ratziu V, Yunis C, Schattenberg JM, Valenti L, Gomez MR, Schuppan D, Petta S, Allison M, Hartman ML, Porthan K, Dufour JF, Bugianesi E, Gastadelli A, Derdak Z, Fournier-Poizat C, Shumbayawonda E, Kalutkiewicz M, Yki-Jarvinen H, Ekstedt M, Geier A, Trylesinski A, Francque S, Brass C, Pavlides M, Holleboom AG, Nieuwdorp M, Anstee QM, Bossuyt PM; LITMUS investigators. Liver Int. 2025 Feb;45(2):e16240. doi: 10.1111/liv.16240. PMID: 39865358

 Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver disease.

Yip TC, Lee HW, Lin H, Tsochatzis E, Petta S, Bugianesi E, Yoneda M, Zheng MH, Hagström H, Boursier J, Calleja JL, Goh GB, Chan WK, Gallego-Durán R, Sanyal AJ, de Lédinghen V, Newsome PN, Fan JG, Castéra L, Lai M, Fournier-Poizat C, Wong GL, Pennisi G, Armandi A, Nakajima A, Liu WY, Shang Y, de Saint-Loup M, Llop E, Teh KKJ, Lara-Romero C, Asgharpour A, Mahgoub S, Chan MS, Canivet CM, Romero-Gomez M, Kim SU, Wong VW. J Hepatol. 2025 Aug;83(2):304-314. doi: 10.1016/j.jhep.2025.01.014. Epub 2025 Jan 23. PMID: 39863175

A new generation of non-invasive tests of liver fibrosis with improved accuracy in MASLD.

Calès P, Canivet CM, Costentin C, Lannes A, Oberti F, Fouchard I, Hunault G, de Lédinghen V, Boursier J. J Hepatol. 2025 May;82(5):794-804. doi: 10.1016/j.jhep.2024.11.049. Epub 2024 Dec 13. PMID: 39674323 

Hepatocellular Cancer Surveillance in Patients with Advanced Chronic Liver Disease.

Gu W, de Lédinghen V, Aubé C, Krag A, Strassburg C, Castéra L, Dumortier J, Friedrich-Rust M, Pol S, Grgurevic I, Zeleke Y, Praktiknjo M, Schierwagen R, Klein S, Francque S, Gottfriedová H, Sporea I, Schindler P, Rennebaum F, Brol MJ, Schulz M, Uschner FE, Fischer J, Margini C, Wang W, Delamarre A, Best J, Canbay A, Bauer DJM, Simbrunner B, Semmler G, Reiberger T, Boursier J, Rasmussen DN, Vilgrain V, Guibal A, Zeuzem S, Vassord C, Vonghia L, Šenkeříková R, Popescu A, Berzigotti A, Laleman W, Thiele M, Jansen C, Trebicka J. NEJM Evid. 2024 Nov;3(11):EVIDoa2400062. doi: 10.1056/EVIDoa2400062. Epub 2024 Oct 22. PMID: 39437136

MASLD-related HCC: Multicenter study comparing patients with and without cirrhosis.

Vitellius C, Desjonqueres E, Lequoy M, Amaddeo G, Fouchard I, N'Kontchou G, Canivet CM, Ziol M, Regnault H, Lannes A, Oberti F, Boursier J, Ganne-Carrie N. JHEP Rep. 2024 Jun 29;6(10):101160. doi: 10.1016/j.jhepr.2024.101160. eCollection 2024 Oct. PMID: 39411648

acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter Study.

Feng G, Mózes FE, Ji D, Treeprasertsuk S, Okanoue T, Shima T, Liang H, Tsochatzis E, Chen J, Schattenberg JM, Labenz C, Mahadeva S, Chan WK, Chi X, Delamarre A, de Lédinghen V, Petta S, Bugianesi E, Hagström H, Boursier J, Calleja JL, Goh GB, Gallego-Durán R, Sanyal AJ, Fan JG, Castéra L, Lai M, Harrison SA, Romero-Gomez M, Kim SU, Zhu Y, Ooi G, Shi J, Yoneda M, Nakajima A, Zhang J, Lupsor-Platon M, Zhong B, Cobbold JFL, Ye CY, Eddowes PJ, Newsome P, Li J, George J, He F, Song MJ, Tang H, Fan Y, Jia J, Xu L, Lin S, Li Y, Lu Z, Nan Y, Niu J, Yan X, Zhou Y, Liu C, Deng H, Ye Q, Zeng QL, Li L, Wang J, Yang S, Lin H, Lee HW, Yip TC, Fournier-Poizat C, Wong GL, Pennisi G, Armandi A, Liu WY, Shang Y, de Saint-Loup M, Llop E, Teh KKJ, Lara-Romero C, Asgharpour A, Mahgoub S, Chan MS, Canivet CM, Ji F, Xin Y, Chai J, Dong Z, Targher G, Byrne CD, He N, Mi M, Ye F, Wong VW, Pavlides M, Zheng MH. Clin Gastroenterol Hepatol. 2025 Apr;23(5):785-796. doi: 10.1016/j.cgh.2024.07.045. Epub 2024 Oct 2. PMID: 39362618

Socioeconomic Deprivation Weighs Heavily on Liver Fibrosis and Mortality After Hepatitis C Cure (ANRS CO22 Hepather).

Barré T, Parlati L, Bourlière M, Ramier C, Marcellin F, Protopopescu C, Di Beo V, Moins C, Dorival C, Nicol J, Zucman-Rossi J, Mathurin P, Larrey D, Boursier J, Carrat F, Carrieri P; ANRS/AFEF Hepather Study group. J Viral Hepat. 2024 Dec;31(12):830-846. doi: 10.1111/jvh.14006. Epub 2024 Sep 10. PMID: 39252600

Fatty Liver Disease Along Cushing Syndrome Evolution.

Marengo M, Briet C, Munier M, Boursier J, Rodien P, Suteau V. J Clin Endocrinol Metab. 2025 May 19;110(6):e2037-e2044. doi: 10.1210/clinem/dgae568. PMID: 39193719

Prevalence of Liver Steatosis and Fibrosis in Adults With Primary Hypobetaliproteinemia: Results From the HYPOCHOL Study.

Smati S, Wargny M, Boursier J, Moulin P, Di Filippo M, Cariou B. Clin Gastroenterol Hepatol. 2025 Jan;23(1):166-168.e4. doi: 10.1016/j.cgh.2024.06.031. Epub 2024 Jul 5. PMID: 38971410 Free article. No abstract available.

Food perception induces fast fragmentation of hepatic mitochondria. 

Chevrollier A, Boursier J, Desquiret-Dumas V. Trends Endocrinol Metab. 2024 Aug;35(8):680-682. doi: 10.1016/j.tem.2024.06.002. Epub 2024 Jun 18. PMID: 38897878 Review.

Review of current and new drugs for the treatment of metabolic-associated fatty liver disease. 

Gish R, Fan JG, Dossaji Z, Fichez J, Laeeq T, Chun M, Boursier J. Hepatol Int. 2024 Oct;18(Suppl 2):977-989. doi: 10.1007/s12072-024-10698-y. Epub 2024 Jun 8. PMID: 38850496

Plasma ALS and Gal-3BP differentiate early from advanced liver fibrosis in MASLD patients.

Pérez Compte D, Etourneau L, Hesse AM, Kraut A, Barthelon J, Sturm N, Borges H, Biennier S, Courçon M, de Saint Loup M, Mignot V, Costentin C, Burger T, Couté Y, Bruley C, Decaens T, Jaquinod M, Boursier J, Brun V. Biomark Res. 2024 Apr 29;12(1):44. doi: 10.1186/s40364-024-00583-z. PMID: 38679739 Free PMC article.

Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis.

Mózes FE, Lee JA, Vali Y, Selvaraj EA, Jayaswal ANA, Boursier J, de Lédinghen V, Lupșor-Platon M, Yilmaz Y, Chan WK, Mahadeva S, Karlas T, Wiegand J, Shalimar, Tsochatzis E, Liguori A, Wong VW, Lee DH, Holleboom AG, van Dijk AM, Mak AL, Hagström H, Akbari C, Hirooka M, Lee DH, Kim W, Okanoue T, Shima T, Nakajima A, Yoneda M, Thuluvath PJ, Li F, Berzigotti A, Mendoza YP, Noureddin M, Truong E, Fournier-Poizat C, Geier A, Tuthill T, Yunis C, Anstee QM, Harrison SA, Bossuyt PM, Pavlides M. Liver Int. 2024 Aug;44(8):1872-1885. doi: 10.1111/liv.15914. Epub 2024 Apr 4. PMID: 38573034 Free article.

New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and Alcohol-Associated Liver Disease, and Their Implications in Clinical Practice.

Canivet CM, Boursier J, Loomba R. Semin Liver Dis. 2024 Feb;44(1):35-42. doi: 10.1055/s-0044-1785196. Epub 2024 Mar 26. PMID: 38531378

Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease.

Lin H, Lee HW, Yip TC, Tsochatzis E, Petta S, Bugianesi E, Yoneda M, Zheng MH, Hagström H, Boursier J, Calleja JL, Goh GB, Chan WK, Gallego-Durán R, Sanyal AJ, de Lédinghen V, Newsome PN, Fan JG, Castéra L, Lai M, Harrison SA, Fournier-Poizat C, Wong GL, Pennisi G, Armandi A, Nakajima A, Liu WY, Shang Y, de Saint-Loup M, Llop E, Teh KK, Lara-Romero C, Asgharpour A, Mahgoub S, Chan MS, Canivet CM, Romero-Gomez M, Kim SU, Wong VW; VCTE-Prognosis Study Group. JAMA. 2024 Apr 16;331(15):1287-1297. doi: 10.1001/jama.2024.1447. PMID: 38512249 Free PMC article.

Primary hypocholesterolemia is associated with an increased risk of hepatic complications in the general population.

Wargny M, Goronflot T, Rimbert A, Boursier J, Kab S, Henny J, Lainé A, Leux C, Smati S, Hadjadj S, Le May C, Goldberg M, Zins M, Cariou B. J Hepatol. 2024 Jun;80(6):846-857. doi: 10.1016/j.jhep.2024.01.030. Epub 2024 Feb 6. PMID: 38331324 Free article.

Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitis.

Francque SM, Hodge A, Boursier J, Younes ZH, Rodriguez-Araujo G, Park GS, Alkhouri N, Abdelmalek MF. Hepatol Commun. 2024 Jan 29;8(2):e0335. doi: 10.1097/HC9.0000000000000335. eCollection 2024 Feb 1. PMID: 38285756 Free PMC article. Clinical Trial.

Reply: Concerns regarding the use of Fatty Liver Index in studies of lean NAFLD.

Nabi O, Lapidus N, Boursier J, de Ledinghen V, Petit JM, Kab S, Renuy A, Zins M, Lacombe K, Serfaty L. Hepatology. 2024 May 1;79(5):E130-E131. doi: 10.1097/HEP.0000000000000755. Epub 2024 Jan 22. PMID: 38252803 No abstract available.

Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.

Zeng Q, Klein C, Caruso S, Maille P, Allende DS, Mínguez B, Iavarone M, Ningarhari M, Casadei-Gardini A, Pedica F, Rimini M, Perbellini R, Boulagnon-Rombi C, Heurgué A, Maggioni M, Rela M, Vij M, Baulande S, Legoix P, Lameiras S; HCC-AI study group; Bruges L, Gnemmi V, Nault JC, Campani C, Rhee H, Park YN, Iñarrairaegui M, Garcia-Porrero G, Argemi J, Sangro B, D'Alessio A, Scheiner B, Pinato DJ, Pinter M, Paradis V, Beaufrère A, Peter S, Rimassa L, Di Tommaso L, Vogel A, Michalak S, Boursier J, Loménie N, Ziol M, Calderaro J. Lancet Oncol. 2023 Dec;24(12):1411-1422. doi: 10.1016/S1470-2045(23)00468-0. Epub 2023 Nov 8. PMID: 37951222

Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol.

Pavlides M, Mózes FE, Akhtar S, Wonders K, Cobbold J, Tunnicliffe EM, Allison M, Godfrey EM, Aithal GP, Francis S, Romero-Gomez M, Castell J, Fernandez-Lizaranzu I, Aller R, González RS, Agustin S, Pericàs JM, Boursier J, Aube C, Ratziu V, Wagner M, Petta S, Antonucci M, Bugianesi E, Faletti R, Miele L, Geier A, Schattenberg JM, Tilman E, Ekstedt M, Lundberg P, Berzigotti A, Huber AT, Papatheodoridis G, Yki-Järvinen H, Porthan K, Schneider MJ, Hockings P, Shumbayawonda E, Banerjee R, Pepin K, Kalutkiewicz M, Ehman RL, Trylesinksi A, Coxson HO; LITMUS Consortium Investigators; Martic M, Yunis C, Tuthill T, Bossuyt PM, Anstee QM, Neubauer S, Harrison S. Contemp Clin Trials. 2023 Nov;134:107352. doi: 10.1016/j.cct.2023.107352. Epub 2023 Oct 4. PMID: 37802221 Free article.

Associations between perfluoroalkyl substances and the severity of non-alcoholic fatty liver disease.

David N, Antignac JP, Roux M, Marchand P, Michalak S, Oberti F, Fouchard I, Lannes A, Blanchet O, Cales P, Blanc EB, Boursier J, Canivet CM. Environ Int. 2023 Oct;180:108235. doi: 10.1016/j.envint.2023.108235. Epub 2023 Sep 27. PMID: 37776622

Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests.

Boursier J, Roux M, Costentin C, Chaigneau J, Fournier-Poizat C, Trylesinski A, Canivet CM, Michalak S, Le Bail B, Paradis V, Bedossa P, Sturm N, de Ledinghen V; AFEF group for the study of liver fibrosis; M118 study group; Newsome PN. Nat Commun. 2023 Aug 26;14(1):5219. doi: 10.1038/s41467-023-40328-4. PMID: 37633932 Free PMC article.

Extracellular vesicles are carriers of adiponectin with insulin-sensitizing and anti-inflammatory properties. 

Blandin A, Amosse J, Froger J, Hilairet G, Durcin M, Fizanne L, Ghesquière V, Prieur X, Chaigneau J, Vergori L, Dray C, Pradère JP, Blandin S, Dupont J, Ducluzeau PH, Dubois S, Boursier J, Cariou B, Le Lay S. Cell Rep. 2023 Aug 29;42(8):112866. doi: 10.1016/j.celrep.2023.112866. Epub 2023 Aug 21. PMID: 37605533 Free article.

Adlercreutzia equolifaciens Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver Disease.

Oñate FP, Chamignon C, Burz SD, Lapaque N, Monnoye M, Philippe C, Bredel M, Chêne L, Farin W, Paillarse JM, Boursier J, Ratziu V, Mousset PY, Doré J, Gérard P, Blottière HM. Int J Mol Sci. 2023 Jul 31;24(15):12232. doi: 10.3390/ijms241512232. PMID: 37569608 Free PMC article.

Confirmatory biomarker diagnostic studies are not needed when transitioning from NAFLD to MASLD.  

The NAFLD burden on mortality and morbidities in general population: A community-based longitudinal study (NASH-CO study).

Nabi O, Lapidus N, Boursier J, de Ledinghen V, Kab S, Renuy A, Zins M, Serfaty L, Lacombe K. Liver Int. 2023 Oct;43(10):2096-2106. doi: 10.1111/liv.15674. Epub 2023 Jul 14. PMID: 37452492

A multisociety Delphi consensus statement on new fatty liver disease nomenclature.

Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne CD, Castro Narro GE, Chowdhury A, Cortez-Pinto H, Cryer DR, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot BG, Korenjak M, Kowdley KV, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell EE, Roden M, Romero-Gómez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN; NAFLD Nomenclature consensus group. Hepatology. 2023 Dec 1;78(6):1966-1986. doi: 10.1097/HEP.0000000000000520. Epub 2023 Jun 24. PMID: 37363821 Free PMC article.

An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease.  

Sun DQ, Targher G, Byrne CD, Wheeler DC, Wong VW, Fan JG, Tilg H, Yuan WJ, Wanner C, Gao X, Long MT, Kanbay M, Nguyen MH, Navaneethan SD, Yilmaz Y, Huang Y, Gani RA, Marzuillo P, Boursier J, Zhang H, Jung CY, Chai J, Valenti L, Papatheodoridis G, Musso G, Wong YJ, El-Kassas M, Méndez-Sánchez N, Sookoian S, Pavlides M, Duseja A, Holleboom AG, Shi J, Chan WK, Fouad Y, Yang J, Treeprasertsuk S, Cortez-Pinto H, Hamaguchi M, Romero-Gomez M, Al Mahtab M, Ocama P, Nakajima A, Dai C, Eslam M, Wei L, George J, Zheng MH. Hepatobiliary Surg Nutr. 2023 Jun 1;12(3):386-403. doi: 10.21037/hbsn-22-421. Epub 2023 Feb 23. PMID: 37351121 Free PMC article. Review.

Reply to: "Agile scores are a good predictor of liver-related events in patients with NAFLD".

Boursier J, Roux M, Sanyal AJ. J Hepatol. 2023 Sep;79(3):e128-e129. doi: 10.1016/j.jhep.2023.05.033. Epub 2023 Jun 9. PMID: 37302579

Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis.

Mózes FE, Lee JA, Vali Y, Alzoubi O, Staufer K, Trauner M, Paternostro R, Stauber RE, Holleboom AG, van Dijk AM, Mak AL, Boursier J, de Saint Loup M, Shima T, Bugianesi E, Gaia S, Armandi A, Shalimar, Lupșor-Platon M, Wong VW, Li G, Wong GL, Cobbold J, Karlas T, Wiegand J, Sebastiani G, Tsochatzis E, Liguori A, Yoneda M, Nakajima A, Hagström H, Akbari C, Hirooka M, Chan WK, Mahadeva S, Rajaram R, Zheng MH, George J, Eslam M, Petta S, Pennisi G, Viganò M, Ridolfo S, Aithal GP, Palaniyappan N, Lee DH, Ekstedt M, Nasr P, Cassinotto C, de Lédinghen V, Berzigotti A, Mendoza YP, Noureddin M, Truong E, Fournier-Poizat C, Geier A, Martic M, Tuthill T, Anstee QM, Harrison SA, Bossuyt PM, Pavlides M; LITMUS investigators.Lancet Gastroenterol Hepatol. 2023 Aug;8(8):704-713. doi: 10.1016/S2468-1253(23)00141-3. Epub 2023 Jun 5.PMID: 37290471 Free article.

An international multidisciplinary consensus statement on MAFLD and the risk of CVD.

Zhou XD, Targher G, Byrne CD, Somers V, Kim SU, Chahal CAA, Wong VW, Cai J, Shapiro MD, Eslam M, Steg PG, Sung KC, Misra A, Li JJ, Brotons C, Huang Y, Papatheodoridis GV, Sun A, Yilmaz Y, Chan WK, Huang H, Méndez-Sánchez N, Alqahtani SA, Cortez-Pinto H, Lip GYH, de Knegt RJ, Ocama P, Romero-Gomez M, Fudim M, Sebastiani G, Son JW, Ryan JD, Ikonomidis I, Treeprasertsuk S, Pastori D, Lupsor-Platon M, Tilg H, Ghazinyan H, Boursier J, Hamaguchi M, Nguyen MH, Fan JG, Goh GB, Al Mahtab M, Hamid S, Perera N, George J, Zheng MH.Hepatol Int. 2023 Aug;17(4):773-791. doi: 10.1007/s12072-023-10543-8. Epub 2023 May 19.PMID: 37204656 Free PMC article.

Validation of the Blood Test MACK-3 for the Noninvasive Diagnosis of Fibrotic Nonalcoholic Steatohepatitis: An International Study With 1924 Patients.

Canivet CM, Zheng MH, Qadri S, Vonghia L, Chuah KH, Costentin C, George J, Armandi A, Adams LA, Lange NF, Blanchet O, Moal V, Younes R, Roux M, Chan WK, Sturm N, Eslam M, Bugianesi E, Wang Z, Dufour JF, Francque S, Yki-Järvinen H, Zheng KI, Boursier J.Clin Gastroenterol Hepatol. 2023 Nov;21(12):3097-3106.e10. doi: 10.1016/j.cgh.2023.03.032. Epub 2023 Apr 7.PMID: 37031715 Free article.

Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes.

Pennisi G, Enea M, Falco V, Aithal GP, Palaniyappan N, Yilmaz Y, Boursier J, Cassinotto C, de Lédinghen V, Chan WK, Mahadeva S, Eddowes P, Newsome P, Karlas T, Wiegand J, Wong VW, Schattenberg JM, Labenz C, Kim W, Lee MS, Lupsor-Platon M, Cobbold JFL, Fan JG, Shen F, Staufer K, Trauner M, Stauber R, Nakajima A, Yoneda M, Bugianesi E, Younes R, Gaia S, Zheng MH, Cammà C, Anstee QM, Mózes FE, Pavlides M, Petta S.Hepatology. 2023 Jul 1;78(1):195-211. doi: 10.1097/HEP.0000000000000351. Epub 2023 Mar 17.PMID: 36924031

Dynamic personalized prediction of the individual liver-related risk after sustained viral response in HCV patients.

Moreau C, Roux M, Riou J, Canivet CM, Audureau E, Lusivika-Nzinga C, Nahon P, Carrat F, Boursier J; ANRS CO12 CirVir group and the ANRS CO22 HEPATHER group.J Viral Hepat. 2023 Jun;30(6):567-577. doi: 10.1111/jvh.13830. Epub 2023 Mar 31.PMID: 36891763

Lipidomic analysis of adipose-derived extracellular vesicles reveals specific EV lipid sorting informative of the obesity metabolic state.

Blandin A, Dugail I, Hilairet G, Ponnaiah M, Ghesquière V, Froger J, Ducheix S, Fizanne L, Boursier J, Cariou B, Lhomme M, Le Lay S.Cell Rep. 2023 Mar 28;42(3):112169. doi: 10.1016/j.celrep.2023.112169. Epub 2023 Mar 1.PMID: 36862553 Free article.

Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study.

Zhang H, Rios RS, Boursier J, Anty R, Chan WK, George J, Yilmaz Y, Wong VW, Fan J, Dufour JF, Papatheodoridis G, Chen L, Schattenberg JM, Shi J, Xu L, Wong GL, Lange NF, Papatheodoridi M, Mi Y, Zhou Y, Byrne CD, Targher G, Feng G, Zheng M.Chin Med J (Engl). 2023 Feb 5;136(3):341-350. doi: 10.1097/CM9.0000000000002603.PMID: 36848175 Free PMC article.

Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study).

Nabi O, Lapidus N, Boursier J, de Ledinghen V, Petit JM, Kab S, Renuy A, Zins M, Lacombe K, Serfaty L.Hepatology. 2023 Jul 1;78(1):272-283. doi: 10.1097/HEP.0000000000000329. Epub 2023 Feb 24.PMID: 36815354

Faeces-derived extracellular vesicles participate in the onset of barrier dysfunction leading to liver diseases.

Fizanne L, Villard A, Benabbou N, Recoquillon S, Soleti R, Delage E, Wertheimer M, Vidal-Gómez X, Oullier T, Chaffron S, Martínez MC, Neunlist M, Boursier J, Andriantsitohaina R.J Extracell Vesicles. 2023 Feb;12(2):e12303. doi: 10.1002/jev2.12303.PMID: 36708245 Free PMC article.

Validation of a screening algorithm for hepatic fibrosis by Doppler ultrasound and elastography in a general population.

Renard AS, Paisant A, Cartier V, Calès P, Goyet-Prelipcean M, Geagea E, Tasu JP, Silvain C, Wagner M, Cleach AL, Vilgrain V, Castera L, Bricault I, Decaens T, Savoye-Collet C, Montialoux H, Correas JM, Vallet-Pichard A, Boursier J, Aubé C.Acta Radiol. 2023 May;64(5):1730-1737. doi: 10.1177/02841851221138519. Epub 2023 Jan 8.PMID: 36617943

Acceptability to Healthcare Professionals of Home-Based HPV Self-Sampling for Cervical Screening: A French Qualitative Study Conducted in an Area with Low Access to Health Services.

Le Goff J, Le Duc-Banaszuk AS, Lefeuvre C, Pivert A, Ducancelle A, De Pauw H, Arbyn M, Vinay A, Rexand-Galais F. 

Residual risk of mother-to-child transmission of hepatitis B despite timely birth dose vaccination in Cameroon (ANRS 12303): a prospective study.

Y Shimakawa; P Veillon; J Birguel; A Pivert; V Sauvage; H Le Guillou-Guillemette; S Roger; R Njouom; A Ducancelle; P Amta; JM Huraux; JP Adoukara; F Lunel-Fabiani.

Study Protocol: Randomised Controlled Trial Assessing the Efficacy of Strategies Involving Self-Sampling in Cervical Cancer Screening.

Lefeuvre C, De Pauw H, Le Duc Banaszuk AS, Pivert A, Ducancelle A, Rexand-Galais F, Arbyn M.

From national HBV and HDV screenings to vaccination and treatment in healthcare workers: The Mauritanian pilot study.

A El Bara, A Pivert, P Veillon, C Ng Wing Sang, M Bollahi, K Abdel, A Ducancelle, H Le Guillou-Guillemette, F Lunel-Fabiani.

Age-Related Expression of IFN-λ1 Versus IFN-I and Beta-Defensins in the Nasopharynx of SARS-CoV-2-Infected Individuals.

Gilbert C, Lefeuvre C, Preisser L, Pivert A, Soleti R, Blanchard S, Delneste Y, Ducancelle A, Couez D, Jeannin P.

Urinary HPV DNA testing as a tool for cervical cancer screening in women who are reluctant to have a Pap smear in France.

Lefeuvre C, Pivert A, Guillou-Guillemette HL, Lunel-Fabiani F, Veillon P, Le Duc-Banaszuk AS, Ducancelle A.

A first experience of transduction for differentiated HepaRG cells using lentiviral technology.

Pivert A, Lefeuvre C, Tran CT, Baillou C, Durantel D, Le Guillou-Guillemette H, Lemoine FM, Lunel-Fabiani F, Ducancelle A.

Two-Phase MDCT Protocol for the Screening of Small Hepatocellular Carcinoma

Anita Paisant, Jérôme Boursier, Djamel Dabli, Jérôme Lebigot, Frédéric Oberti, Sophie Michalak, Valérie Vilgrain, Christophe Aubé.

Noninvasive Algorithms for the Case Finding of “At-Risk” Patients with NAFLD

Laurent Castera, Jérôme Boursier.

Analysis of hepatic fibrosis markers in the serum of chronic hepatitis B patients according to basal core promoter/precore mutants

Caroline Lefeuvre, Marine Roux, Simon Blanchard, Hélène Le Guillou-Guillemette, Jérôme Boursier et al. 

 Systematic screening for advanced liver fibrosis in patients with coronary artery disease: The CORONASH study

Thierry Thévenot, Sophie Vendeville, Delphine Weil, Linda Akkouche, Paul Calame et al.

 Comparison of performance between three SARS‐CoV‐2 molecular assays (Aptima™, Laboratory Developed Test‐Fusion, and R‐GENE®) with special attention to turnaround time, a key point in laboratory management

Caroline Lefeuvre, Adeline Pivert, Emilie Przyrowski, Elise Bouthry, Estelle Darviot et al.

Antibiotic resistance in chronic respiratory diseases: from susceptibility testing to the resistome

Hélène Pailhoriès, Jean-Louis Herrmann, Lourdes Velo-Suarez, Claudie Lamoureux, Clémence Beauruelle et al.  

Awareness of chronic liver diseases, a comparison between diabetologists and general practitioners

Clémence Canivet, Sarra Smati, Adrien Lannes, Julie Brisseau, Louise Judon et al.

What is the true place of the SARS‐CoV‐2 rapid point‐of‐care antigen test in the hospital setting? Lessons learned from real life

Steven Roger, Caroline Lefeuvre, Adeline Pivert, Alexandra Ducancelle, Dominique Savary et al. 

Determinants of the severity of fatty liver diseases: Need all the pieces to solve the puzzle

Hélène Pailhoriès, Jerome Boursier, Anna Mae Diehl. 

Quality criteria for the measurement of liver stiffness

Jérôme Boursier, Marie Decraecker, Marc Bourlière, Christophe Bureau, Nathalie Ganne-Carrié, Victor de Lédinghen

Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study

E. Trepo, S Caruso, J. Yang, S Imbeaud, G Couchy et al.  

Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD

Clémence Canivet, Charlotte Costentin, Katharina Irvine, Adèle Delamarre, Adrien Lannes et al. 

The burden of NAFLD in type 2 diabetic subjects from the general population: A Nationwide population-based follow-up study (NASHCO)

Oumarou Nabi, Jérôme Boursier, Nathanaël Lapidus, Philippe H. Mathurin, Victor de Ledinghen et al.

Obstetrical anal sphincter injury and unnecessary episiotomy are both associated with anal incontinence 8 years after childbirth: A nationwide database analysis

Mathieu Levaillant, Guillaume Legendre, Emeline Rebmann, Jean-François Hamel, Aurélien Venara. 

Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020

Samuel Alizon, Christian Selinger, Mircea Sofonea, Stéphanie Haim-Boukobza, Jean-Marc Giannoli et al.

Kidney function monitoring in inflammatory bowel disease: The MONITORED consensus

Lucas Guillo, Pierre Delanaye, Martin Flamant, Lucile Figueres, Sabine Karam et al.

A Pleiotropic Role of the Hepatitis B Virus Core Protein in Hepatocarcinogenesis

Caroline Lefeuvre, Hélène Le Guillou-Guillemette, Alexandra Ducancelle. 

A rapid and simple method for assessing and representing genome sequence relatedness

Martial Briand, M Bouzid, G Hunault, M Legeay, Marion Fischer-Le Saux et al.

Humoral response to a third injection of BNT162b2 vaccine in patients on maintenance haemodialysis

Marine Dekervel, Nicolas Henry, Massimo Torreggiani, Lise-Marie Pouteau, Jean-Paul Imiela et al.

acNASH index to diagnose nonalcoholic steatohepatitis: a prospective derivation and global validation study

Xi-Xi Wu, Kenneth Zheng, Jérôme Boursier, Wah-Kheong Chan, Yusuf Yilmaz et al.

Evaluation of the Hepatorenal B-Mode Ratio and the “Controlled Attenuation Parameter” for the Detection and Grading of Steatosis

Antoine Moret, Jérome Boursier, Pauline Houssel Debry, Jérémie Riou, Anne Crouan et al.

Liver fibrosis staging by computed tomography: prospective randomized multicentric evaluation of image analyses

Carole Vitellius, Anita Paisant, Adrien Lannes, Julien Chaigneau, Frédéric Obertiet al.